Main Page Content

News Teaser
News Thumb
Promising_results_in_a_Global_Phase_III_Stroke_Trial,_fueled_by_UHN_ResearchPromising results in a Global Phase III Stroke Trial, fueled by UHN Research
A new study published in The Lancet shows the strong promise for efficacy of a drug called nerinetide (NA-1) for stroke patients. The research began at UHN.
Dr. Michael Tymianski
Nothing_to_lose_and_everything_to_gain‘Nothing to lose and everything to gain’
Peter Munk Cardiac Centre patient Bill George says Left Ventricular Assist Device (LVAD) implant has given him “a completely new outlook on life.”
Bill and Grandchildren
New_program_brings_life_saving_treatment_to_cancer_patientsNew program brings life-saving treatment to cancer patients
New cellular therapy program at the Princess Margaret marks a new era in realizing the full potential of immunotherapy treatments for cancer patients.
Women with red glasses

Read all our News stories »


​​​​​​​​​​​​​​​​​​​​​​​​Get In T​​​​ouch

Our Public Affairs & Communications team is ready to respond to journalists’ inquiries and requests. Contact one of our site representatives or call our media line, and we will be happy to help.  

Connect With UHN

social media- Facebook     
social media- Twitter     
social media- Youtube     
social media- LinkedIn     

All UHN Social Media  »   


Read Our Blogs